[go: up one dir, main page]

FR3123802B3 - Gas mixture based on argon and helium usable in case of ischemic stroke - Google Patents

Gas mixture based on argon and helium usable in case of ischemic stroke Download PDF

Info

Publication number
FR3123802B3
FR3123802B3 FR2106333A FR2106333A FR3123802B3 FR 3123802 B3 FR3123802 B3 FR 3123802B3 FR 2106333 A FR2106333 A FR 2106333A FR 2106333 A FR2106333 A FR 2106333A FR 3123802 B3 FR3123802 B3 FR 3123802B3
Authority
FR
France
Prior art keywords
helium
argon
usable
mixture based
case
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2106333A
Other languages
French (fr)
Other versions
FR3123802A3 (en
Inventor
Géraldine Farjot
Catherine Billoet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
Original Assignee
LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude filed Critical LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
Priority to FR2106333A priority Critical patent/FR3123802B3/en
Publication of FR3123802A3 publication Critical patent/FR3123802A3/en
Application granted granted Critical
Publication of FR3123802B3 publication Critical patent/FR3123802B3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/12Preparation of respiratory gases or vapours by mixing different gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0208Oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/025Helium

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Titre de l’invention Mélange gazeux à base d’argon et d’hélium utilisable en cas d’accident vasculaire cérébral ischémique L’invention concerne un médicament gazeux inhalable contenant de l’argon, de l’hélium et de l’oxygène gazeux, en particulier un mélange ternaire constitué d’argon, d’hélium et d’oxygène, pour une utilisation pour traiter, atténuer ou résorber des lésions cérébrales consécutives à un accident vasculaire cérébral ischémique (AVCi) chez un individu devant subir une thrombectomie mécanique, avec ou sans thrombolyse. Figure de l’abrégé : AucuneTitle of the invention Gaseous mixture based on argon and helium usable in the event of ischemic cerebrovascular accident The invention relates to an inhalable gaseous medicine containing argon, helium and oxygen gas, in particular a ternary mixture consisting of argon, helium and oxygen, for use in treating, attenuating or resorbing brain damage following an ischemic cerebrovascular accident (CVA) in an individual undergoing mechanical thrombectomy, with or without thrombolysis. Abstract Figure: None

FR2106333A 2021-06-15 2021-06-15 Gas mixture based on argon and helium usable in case of ischemic stroke Active FR3123802B3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR2106333A FR3123802B3 (en) 2021-06-15 2021-06-15 Gas mixture based on argon and helium usable in case of ischemic stroke

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2106333A FR3123802B3 (en) 2021-06-15 2021-06-15 Gas mixture based on argon and helium usable in case of ischemic stroke
FR2106333 2021-06-15

Publications (2)

Publication Number Publication Date
FR3123802A3 FR3123802A3 (en) 2022-12-16
FR3123802B3 true FR3123802B3 (en) 2023-08-11

Family

ID=84424421

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2106333A Active FR3123802B3 (en) 2021-06-15 2021-06-15 Gas mixture based on argon and helium usable in case of ischemic stroke

Country Status (1)

Country Link
FR (1) FR3123802B3 (en)

Also Published As

Publication number Publication date
FR3123802A3 (en) 2022-12-16

Similar Documents

Publication Publication Date Title
MA29283B1 (en) PROCESS FOR THE ENRICHMENT OF OXYGEN IN GASES, CORRESPONDING DEVICES AND THEIR USE
FR3123802B3 (en) Gas mixture based on argon and helium usable in case of ischemic stroke
MA31852B1 (en) CRYOGENIC TREATMENT OF GAS
FR3123803B3 (en) Gas mixture usable in case of ischemic stroke
Timperi A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB)
JP2007222942A (en) TITANIUM LASER CUTTING WITH Ar/He GAS MIXTURE
BR0204223A (en) Low pressure carburizing process
RU2367715C2 (en) Nitriding method of products made of allyed steel
DE502004008688D1 (en) METHOD FOR LASER RADIATION WELDING
FR3137845B1 (en) Process for the purification of 1,1,1,2,3,3-hexafluoropropane
FR3059840B1 (en) GASEOUS MIXTURE TO EXTEND THE LIFE OF A CARBON DIOXIDE LASER
Desante et al. THE HEALING OF HYDROGEN-INDUCED MICROCRACKS IN IRON-3% SILICON.
FR3118064B1 (en) Non-magnetic timepieces and thermomechanical treatment process for obtaining such parts.
Sorout . Kitab-Ul-hind
Hipparagi Transgender Narratives in Postcolonial India: Intersections and Divergences A Study of Select Autobiographies.
Hill et al. Hybridisation of diamond with silicon photonic resonators
Pai THE HUMAN SIDE OF TECHNOLOGY: AI'S SOCIAL IMPACT ON ENGINEERING STUDENTS
Ling Peniel E. Joseph, The Sword and the Shield: The Revolutionary Lives of Malcolm X and Martin Luther King Jr.(New York: Basic Books, 2020,£ 25.00). Pp. 384. ISBN 978 1 5416 1786 5.
Staff Author says Cuba Possesses Advanced Biological Weapons
DE POLI At the Origins of Egyptian Nationalism: The Political Role of Italian Freemasons in 19th-Century Egypt
Wolfson THE INFLUENCE OF INERT AND CHEMICALLY REACTIVE ADDITIVES ON THE MECHANISM OF DE/ONATION IN GASEOUS MIXTURES OVER WIDE RANGES OF INITIAL PRESSURE AND ADDITIVE CONCENTRATION
RU2019134756A (en) METHOD FOR INCREASING THE LIFE LIFE LIFE
Gawlas-Zajączkowska The Polish Government’s Migration Policy towards Jews in the Interwar Period
Schors Jewish Soldiers in Nazi Captivity: American and British Prisoners of War During the Second World War By Yorai Linenberg. Oxford: Oxford University Press, 2023. Pp. xii+ 270. Cloth $110.00. ISBN: 978-0198892786.
Syamsuddin A Critical Analysis of Modern Society of NEOM City in One-Dimensional Man Concept Herbert Marcuse

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5